Skip to content
Download PDF

The Human Microbiome in Health and Disease

Chapter 484 | Harrison's 22e · Parts 15-16 – Genetics, Genomics & Precision Medicine · Chapter 484

Key Clinical Points

  1. Humans are defined as a 'holobiont': a complex assemblage of human cells and microorganisms (bacteria, viruses, fungi, and Archaea) that interact to drive normal physiologic processes.
  2. The microbiome is highly site-specific; different anatomical locations harbor distinct microbial communities with unique compositions.
  3. Microbiota alterations are linked to various conditions: intestinal disorders, metabolic dysfunction, autoimmune diseases, and psychiatric conditions.
  4. The microbiome significantly influences host susceptibility to infection and the efficacy of pharmaceutical therapies.
  5. A critical area of research is determining whether microbiome changes are mere biomarkers of disease, a causal relationship, or both.
  6. Large-scale projects (HMP, MetaHIT) combined with advanced sequencing and gnotobiotic models have revolutionized our understanding of microbial interactions.
  7. The 'Hygiene Hypothesis' suggests an inverse relationship between the decline of infectious diseases and the rise of autoimmune/allergic conditions.
  8. Microbial ecosystems can be modeled as 'stability landscapes' where health and disease are distinct, stable states (basins).
  9. While taxonomic composition varies significantly by site, the microbiome provides a wide range of essential metabolic functions.

DEFINITION & CLASSIFICATION

• Holobiont Concept ◦ Definition: A complex assemblage of human cells and microorganisms interacting in an elaborate pas de deux that drives normal physiologic processes. ◦ Microbial Components: → Bacteria → Viruses → Fungi → Archaea

HISTORICAL PERSPECTIVE

• Early Observations (1683): ◦ Antony van Leeuwenhoek first observed "very little living animalcules" in dental plaque. • Early Microbiota Studies: ◦ Leeuwenhoek performed the first comparative studies to assess how oral microbes changed based on: → Age spectrum (e.g., young children vs. old men) → Lifestyle factors (e.g., alcoholism and tobacco use)

ETIOLOGY & PATHOPHYYSOLOGY

• Impact on Physiology: ◦ The microbiome is vital to human well-being. • Clinical Associations: ◦ Intestinal disorders ◦ Disturbances in metabolic function ◦ Autoimmune diseases ◦ Psychiatric conditions • Host Interactions: ◦ Influence on susceptibility to infection ◦ Influence on the efficacy of pharmaceutical therapies. • Causality vs. Biomarker: ◦ Research is ongoing to determine if alterations are: → Mere biomarkers of disease → A causal relationship → A combination of both.

DIAGNOSTIC APPROACH

• Research & Mapping Tools: ◦ Large-scale Projects: Human Microbiome Project (HMP) and MetaHIT to catalog bacteria at multiple body sites. ◦ Advanced Technologies: → Advanced sequencing technologies (Chapter 126) → Gnotobiotic animal availability → Microbial culture techniques

MANAGEMENT & TREATMENT

• Clinical Implications of Microbiome Knowledge: ◦ Therapeutic Potential: Understanding host-commensal interactions is key to developing clinically meaningful interventions. ◦ Impact on Treatment Efficacy: → Influence on the effectiveness of pharmaceutical therapies. → Impact on susceptibility to infection. • Ecological Stability Model: → Stability Landscapes: Microbial ecosystems exist in stable states (basins). → State Shifts: Clinical changes (e.g., administration of antibiotics) can shift the microbial population from a healthy state to a disease state.